par 210 par 210 (Propafenone Hydrochloride Extended Release 325 mg)
Pill with imprint par 210 par 210 is Orange & White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended Release 325 mg. It is supplied by Par Pharmaceutical Inc.
Propafenone is used in the treatment of atrial fibrillation; atrial flutter; wolff-parkinson-white syndrome; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 325 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for par 210 par 210
Propafenone Hydrochloride Extended Release
- Imprint:
- par 210 par 210
- Strength:
- 325 mg
- Color:
- Orange & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Par Pharmaceutical Inc
- Inactive Ingredients:
- lactose anhydrous
magnesium stearate
povidone
FD&C Blue No. 1
gelatin
titanium dioxide
D&C Yellow No. 10
ferrosoferric oxide
butyl alcohol
propylene glycol
FD&C Blue No. 2
FD&C Red No. 40
shellac
alcohol
water
ethylcelluloses
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 68084-0917 | Amerisource Health Services |
| 42291-0546 | AvKare, Inc. |
More about propafenone
- Propafenone Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 51 Reviews
- Drug class: group I antiarrhythmics
- FDA Alerts (1)
Consumer resources
- Propafenone
- Propafenone Tablets
- Propafenone Sustained-Release Capsules
- Propafenone (Advanced Reading)
Other brands: Rythmol, Rythmol SR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
